标准EVAR术后电视腹腔镜引导下囊腔造影与直接囊腔栓塞
本研究回顾性分析2016至2022年本机构259例标准EVAR中63例(24.3%)II型内漏患者,其中14例(5.4%)因囊腔增大接受电视腹腔镜引导下囊腔造影与直接囊腔栓塞(ViSE)。中位随访32.4个月后,2例囊腔增大需手术转换,无主动脉相关死亡。作者认为ViSE可作为T2EL伴囊腔增大患者的可选替代方案。
要点
- ViSE技术成功率87%(12/14),中位手术时间140分钟,中位透视时间40.5分钟。
- ViSE术中发现5例(35%)隐匿性I型或III型内漏,需即刻或分期附加处理。
- 中位随访32.4个月,2例囊腔增大需手术转换,无主动脉相关死亡。
核心结论
- 作者认为,对于T2EL伴囊腔增大的患者,电视腹腔镜引导下囊腔造影与直接囊腔栓塞(ViSE)可考虑作为有效的替代方案。
- 作者早期经验显示ViSE在处理瘤巢和肠系膜下动脉以及识别隐匿性I型或III型内漏方面安全有效。
研究设计与样本
- 回顾性分析本机构2016至2022年前瞻性维护的接受标准EVAR的患者登记数据。
- 排除标准包括:CT诊断的同时存在I型或III型内漏、随访不足6个月、或无可用影像学资料供回顾。
- 禁忌证包括:内漏瘤巢位于内移植物主体后方、以及困难腹部(严重肥胖BMI>35 kg/m2、既往开放手术史、或腹膜炎病史)。
- 研究期间共完成259例标准EVAR,63例(24.3%)存在T2EL,其中26例因随访期间显著囊腔增大接受血管内治疗,14例(5.4%)接受ViSE并纳入研究。
主要发现
- 中位手术时间和中位透视时间分别为140分钟(IQR=105-150)和40.5分钟(IQR=31-45)。
- 技术成功12/14例(87%)。
- 7例(50%)患者行肠系膜下动脉(IMA)结扎。
- 5例(35%)患者发现隐匿性I型或III型内漏,需即刻或分期附加手术。
- 中位随访32.4个月(IQR=25.3-51.7)后,2例患者出现囊腔增大并需手术转换;无患者死于主动脉相关原因。
临床怎么用
- 作者认为ViSE可考虑用于T2EL伴囊腔增大的患者。
- 作者早期经验显示ViSE在处理瘤巢和IMA以及识别隐匿性I型或III型内漏方面安全有效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The occurrence of type II endoleak (T2EL) presents a significant challenge in standard endovascular aneurysm repair (EVAR), with ongoing debate in the literature regarding its optimal management. Although spontaneous resolution has been observed in many cases, intervention is often required to prevent progressive sac enlargement and rupture. Various approaches have been described, including translumbar, transarterial, and transcaval embolization, as well as direct sac puncture. The aim of this study is to evaluate the role of videolaparoscopic-guided saccography and direct sac embolization (ViSE) in patients with sac enlargement following EVAR. METHODS: A prospectively maintained registry of patients undergoing standard EVAR between 2016 and 2022 at our institution was retrospectively reviewed. Exclusion criteria included concomitant computed tomography (CT)-diagnosed type I endoleak or type III endoleak (T1EL or T3EL), less than 6 months of follow-up, or no available imaging study for review. A nidus posterior to the main body of endograft and a hostile abdomen (severe obesity body mass index [BMI] >35 kg/m2, previous open surgery, or history of peritonitis) were considered contraindications to ViSE. RESULTS: A total of 259 standard EVAR procedures were performed during the study period, with 63 patients (24.3%) identified as having T2EL, 26 underwent endovascular treatment for significant sac growth during follow-up; 14 of these patients received ViSE (5.4%) and were included in the study. The median procedure time and median fluoroscopic time were 140 (interquartile range [IQR]=105-150) and 40.5 (IQR=31-45) minutes, respectively. Technical success was achieved in 12 of 14 patients (87%). In 7 patients (50%), the inferior mesenteric artery (IMA) was ligated. An occult T1EL or T3EL endoleak was revealed in 5 patients (35%), requiring an immediate or staged adjunct procedure. After a median follow-up of 32.4 months (IQR=25.3-51.7), 2 patients presented sac growth and required surgical conversion. None of the patients died due to aortic-related causes. CONCLUSION: Videolaparoscopic-guided saccography and direct sac embolization may be considered a valid alternative in patients with T2EL and sac growth. In our early experience, it has proven to be safe and effective in treating the nidus and IMA, and identifying hidden T1EL or T3EL.Clinical ImpactVideolaparoscopic-guided saccography and direct sac embolization (ViSE) represent a valuable option for managing type II endoleak (T2EL) with sac enlargement after EVAR. This approach allows precise treatment of the nidus and the inferior mesenteric artery while also identifying undetected type I and III endoleaks that may require further intervention. By integrating ViSE into clinical practice, physicians can improve diagnostic accuracy and expand treatment strategies for complex endoleak cases. The technique enhances endovascular options, potentially reducing the need for open conversion and improving long-term outcomes in patients with persistent sac growth.
引用
- Mezzetto L, Grosso L, D'Oria M, et al. Videolaparoscopic-Guided Saccography and Direct Sac Embolization After Standard EVAR. J Endovasc Ther. 2025. PMID: 40012302. doi:10.1177/15266028251320805
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。